We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Level up your trading with our powerful tools and real-time insights all in one place.
The current PROG market cap is 20.97M. The company's latest EPS is USD -5.2360 and P/E is -0.13.
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 80k | 14k | 2k | 2k | 0 |
| Operating Income | -13.89M | -13.78M | -15.54M | -14.93M | -23.32M |
| Net Income | -5.11M | -13.72M | -17.44M | -17.81M | -73.45M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 143.99M | 74.31M | 1.25M | 305k | 4k |
| Operating Income | -140.12M | -195.19M | -117.84M | -61.78M | -67.14M |
| Net Income | -228.83M | -192.8M | -247.41M | -38.16M | -124.12M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 62.61M | 53.53M | 53.24M | 49.67M | 34.7M |
| Total Liabilities | 160.06M | 155.81M | 158.24M | 170.55M | 153.49M |
| Total Equity | -97.44M | -102.29M | -105M | -120.88M | -118.79M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 101.73M | 154.44M | 108.84M | 53.53M | 31.22M |
| Total Liabilities | 185.6M | 261.43M | 193.82M | 155.81M | 132.64M |
| Total Equity | -83.87M | -106.99M | -84.98M | -102.29M | -101.42M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -53.4M | -64.42M | -12.1M | -23.72M | -34.75M |
| Investing | -720k | -792k | -6k | -25k | -26k |
| Financing | 2.78M | 7.3M | 12.08M | 19.71M | 16.86M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -106.12M | -165.74M | -167.49M | -64.42M | -48.5M |
| Investing | 16.53M | -4.94M | -1.24M | -792k | 2.44M |
| Financing | 73.64M | 229.72M | 165.05M | 7.3M | 30.78M |
| Market Cap | 20.97M |
| Price to Earnings Ratio | -0.13 |
| Price to Sales Ratio | 3.5k |
| Price to Cash Ratio | 1.09 |
| Price to Book Ratio | -0.16 |
| Dividend Yield | - |
| Shares Outstanding | 23.7M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | - |
| 52 Week High | - |
| 52 Week Low | - |
| Spread (Intraday) | 0.01 (0.62%) |
| Company Name | Biora Therapeutics Inc |
| Address |
850 new burton road dover, delaware 19904 |
| Website | https://www.bicara.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
